Carcinoma, Pancreatic Ductal - 27 Studies Found
Active, not recruiting |
: Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma : Metastatic Pancreatic Ductal Adenocarcinoma : 2015-08-27 :
|
Completed |
: Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer : Pancreatic Ductal Adenocarcinoma : 2012-04-13 : Drug: INNO-206 INNO-206 at a total dose of 350 mg/m2 (260 mg/m2 doxorubicin equivalent) will be administ |
Completed |
: A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors :
|
Enrolling by invitation |
: Clinical Trial of Pancreatic Cancer in Stockholm. : Pancreatic Cancer : 2014-06-11 : Procedure: Pancreatic Surgery Surgical removal of the pancreatic tumour (cancer) in the intervention gro |
Active, not recruiting |
: PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer : Metastatic Pancreatic Cancer : 2013-04-22 :
|